EndpointManuscript_revision_SUPPLEMENTARY_MATERIAL.pdf (1.76 MB)
0/0

EndpointManuscript_revision_SUPPLEMENTARY_MATERIAL – Supplemental material for Endpoints for randomized controlled clinical trials for COVID-19 treatments

Download (1.76 MB)
journal contribution
posted on 18.07.2020 by Lori E Dodd, Dean Follmann, Jing Wang, Franz Koenig, Lisa L Korn, Christian Schoergenhofer, Michael Proschan, Sally Hunsberger, Tyler Bonnett, Mat Makowski, Drifa Belhadi, Yeming Wang, Bin Cao, France Mentre, Thomas Jaki

Supplemental material, EndpointManuscript_revision_SUPPLEMENTARY_MATERIAL for Endpoints for randomized controlled clinical trials for COVID-19 treatments by Lori E Dodd, Dean Follmann, Jing Wang, Franz Koenig, Lisa L Korn, Christian Schoergenhofer, Michael Proschan, Sally Hunsberger, Tyler Bonnett, Mat Makowski, Drifa Belhadi, Yeming Wang, Bin Cao, France Mentre and Thomas Jaki in Clinical Trials

Funding

national cancer institute

History

Exports